arrow
R

Robin Michelet

freie universität berlin
H指数:15
被引数:1,025

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization

基于生理学驱动的序贯性群体模型对白蛋白趋势和 vedolizumab 药代动力学的建模,用于妊娠期给药方案优化

2025-12-140
OAAI
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)

TLD-1,一种新型脂质体多柔比星,在实体瘤患者中的比较药代动力学及一项多中心Ⅰ期研究(SAKK 65/16)的最终结果

2025-11-180
PRE
Author’s Reply to Helsby and Hannam: ‘Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights’

作者对Helsby和Hannam的回复:‘理解伏立康唑代谢:一个整合体外和临床见解的中间-外生理基础药代动力学建模框架’

2025-08-010
OAAI
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study

基于模型识别的危重症患者接受SLEDD治疗时美罗培南优化给药策略:一项观察性研究

2025-04-250
OA
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort
2024-03-181
OAAI
Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients

小儿先天性肾上腺皮质增生症患者干血斑中的模型通知目标早晨17 α-羟孕酮浓度

2023-03-213
OAAI
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review

在英夫利昔单抗群体药代动力学模型中,溃疡性结肠炎和急性重度溃疡性结肠炎患者被忽视: 综合评价的结果

2022-09-303
OAAI